0001593968-23-001051.txt : 20230627 0001593968-23-001051.hdr.sgml : 20230627 20230627121442 ACCESSION NUMBER: 0001593968-23-001051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230623 FILED AS OF DATE: 20230627 DATE AS OF CHANGE: 20230627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HO WILLIAM CENTRAL INDEX KEY: 0001400901 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 231045194 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 primary_01.xml PRIMARY DOCUMENT X0407 4 2023-06-23 0001673772 RAPT Therapeutics, Inc. RAPT 0001400901 HO WILLIAM C/O RAPT THERAPEUTICS, INC., 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false Chief Medical Officer false Common Stock 2023-06-23 4 M false 920 12 A 23329 D Employee Stock Option (right to buy) 12 2023-06-23 4 M false 920 0 D 2029-10-29 Common Stock 920 2301 D Includes 1,417 shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on April 28, 2023. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. /s/ Rodney Young, Attorney-in-Fact for William Ho 2023-06-27